Pfizer has completed its exit from Haleon, selling its entire stake for $3.1 billion. BlackRock's unit is now Haleon's ...

Pfizer is wrapping up its lucrative goodbye to Haleon, raising approximately $3.3 billion by offloading its remaining 7.3% ...

Pfizer will sell its remaining stake in British consumer healthcare group Haleon , the companies said on Tuesday.

Curevo has set its sights on competing with GSK’s shingles vaccine dominance by securing $110m and securing a former ...

The top lateral moves list included several important hires from across the state. But there were 10 more jumps that took place over the course of 2024 that deserve another look.

Dozens of foreign CEOs will visit Beijing this month for a flagship business conference and some will meet with President Xi ...

Dozens of foreign CEOs will visit Beijing this month for a flagship business conference and some will meet with President Xi ...

Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110 million in a Series B ...

In its effort to rival GSK’s shingles vaccine Shingrix, Curevo Vaccine has circled up $110 million and recruited two former ...

Amezosvatein has shown excellent immunogenicity and improved tolerability in Phase 2 study -- Medicxi leads round, joined by new investors ...